Skip to main content
. Author manuscript; available in PMC: 2017 Apr 1.
Published in final edited form as: J Nutr Biochem. 2016 Jan 11;30:126–132. doi: 10.1016/j.jnutbio.2015.12.010

Figure 1. Overview of the FFAME Transcriptomic Study.

Figure 1

European ancestry subjects receiving “high-dose” n-3 PUFA (3600mg/day EPA/DHA; n=8) vs. placebo (n=8) were selected for adipose tissue RNASeq at baseline (pre-treatment), after 6–8 weeks supplementation (pre-LPS), and 4-hours following LPS (post-LPS).